Efficacy of prophylactic use of sotalol versus amiodarone in the prevention of new onset post operative atrial fibrillation post off pump coronary artery bypass surgery

Jaistri Jaishankar; Karthik Raman; Siva Muthukumar; Sanjay Theodore

doi:10.18203/2320-6012.ijrms20263712

Authors

Jaistri Jaishankar Department of Cardiothoracic and Vascular Surgery, Chettinad Hospital and Research Institute, Chennai, Tamil Nadu, India
Karthik Raman Department of Cardiothoracic and Vascular Surgery, Chettinad Hospital and Research Institute, Chennai, Tamil Nadu, India
Siva Muthukumar Department of Cardiothoracic and Vascular Surgery, Chettinad Hospital and Research Institute, Chennai, Tamil Nadu, India
Sanjay Theodore Department of Cardiothoracic and Vascular Surgery, Chettinad Hospital and Research Institute, Chennai, Tamil Nadu, India

DOI:

https://doi.org/10.18203/2320-6012.ijrms20263712

Keywords:

Sotalol, Amiodarone, Post operative atrial fibrillation, Off pump coronary artery bypass surgery

Abstract

Background: Atrial fibrillation (AF) is one of the most common arrhythmias following cardiac surgery, occurring in 20-40% of cases, and contributes significantly to increased ICU and hospital stay. While studies exist on sotalol and amiodarone individually for preventing new-onset AF post off-pump CABG, no study has directly compared their effectiveness.

Methods: Seventy-two patients undergoing off-pump CABG were randomised equally into two groups of 36. Group A received IV Amiodarone 6 mg/kg 30 minutes pre-incision, continued as oral Amiodarone 200 mg BD for 3 days then 100 mg BD for 2 days postoperatively. Group S received oral Sotalol 80 mg on the morning of surgery, continued at 80 mg BD postoperatively. Included patients had diabetes mellitus, hypertension, and preserved LV systolic function. Exclusion criteria comprised of COPD, CKD, PVD, moderate-to-severe LV dysfunction, emergency surgery, and pre-existing AF.

Results: Post-operative AF (POAF) occurred in 25% of Group A and 27.77% of Group S, with all cases presenting on post-operative day 2. No statistically significant differences were found between groups across heart rate, blood pressure, graft count, inotropic score, ICU stay, hospital stay, or ventilation duration. The only notable difference was cost Rs.170 for amiodarone versus Rs.10 for sotalol favouring sotalol.

Conclusions: Amiodarone and sotalol demonstrated comparable efficacy in preventing POAF following off-pump CABG. A larger study with broader inclusion criteria is recommended to better define the relative effectiveness of both agents.

References

Ommen SR, Odell JA, Stanton MS. Atrial arrhythmias after cardiothoracic surgery. N Engl J Med. 1997;336(20):1429-34.

Borzak S, Tisdale JE, Amin NB, Goldberg AD, Frank D, Padhi ID, et al. Atrial fibrillation after bypass surgery: does the arrhythmia or the characteristics of the patients prolong hospital stay? Chest. 1998;113(6):1489-91.

Andrews TC, Reimold SC, Berlin JA, Antman EM. Prevention of supraventricular arrhythmias after coronary artery bypass surgery: a meta-analysis of randomized control trials. Circulation. 1991;84(5 Suppl):III236-44.

Kowey PR, Taylor JE, Rials SJ, Marinchak RA. Meta-analysis of the effectiveness of prophylactic drug therapy in preventing supraventricular arrhythmia early after coronary artery bypass grafting. Am J Cardiol. 1992;69(9):963-5.

Babin-Ebell J, Keith PR, Elert O. Efficacy and safety of low-dose propranolol versus diltiazem in the prophylaxis of supraventricular tachyarrhythmia after coronary artery bypass grafting. Eur J Cardiothorac Surg. 1996;10(6):412-6.

Wurdeman RL, Mooss AN, Mohiuddin SM, Lenz TL. Amiodarone vs sotalol as prophylaxis against atrial fibrillation/flutter after heart surgery: a meta-analysis. Chest. 2002;121(4):1203-10.

Evrard P, Gonzalez M, Jamart J, Malhomme B, Blommaert D, Eucher P, et al. Prophylaxis of supraventricular and ventricular arrhythmias after coronary artery bypass grafting with low-dose sotalol. Ann Thorac Surg. 2000;70(1):151-6.

Ji Y, Takanari H, Qile M, Nalos L, Houtman MJC, Romunde FL, et al. Class III antiarrhythmic drugs amiodarone and dronedarone impair KIR2.1 backward trafficking. J Cell Mol Med. 2017;21(10):2514-23.

Moshiri E, Dadashpoor N, Golestani-Eraghi M, Taheri-Nejad MR, Mohammadbeigi A. Prophylactic effect of amiodarone in atrial fibrillation after coronary artery bypass surgery: a double-blind randomized controlled clinical trial. J Cardiovasc Dis Res. 2015;6(1):12-7.

Kim HL, Seo JB, Chung WY, Kim SH, Kim MA, Zo JH. The incidence and predictors of overall adverse effects caused by low-dose amiodarone in real-world clinical practice. Korean J Intern Med. 2014;29(5):588-96.

Taha A, Nielsen SJ, Bergfeldt L, Ahlsson A, Friberg L, Björck S, et al. New-onset atrial fibrillation after coronary artery bypass grafting and long-term outcome: a population-based nationwide study from the SWEDEHEART registry. J Am Heart Assoc. 2021;10(1):e017966.

Gillinov AM, Bagiella E, Moskowitz AJ, Raiten JM, Groh MA, Bowdish ME, et al. Rate control versus rhythm control for atrial fibrillation after cardiac surgery. N Engl J Med. 2016;374(20):1911-21.

Benedetto U, Gaudino MF, Dimagli A, Gerry S, Gray A, Lees B, et al. Postoperative atrial fibrillation and long-term risk of stroke after isolated coronary artery bypass graft surgery. Circulation. 2020;142(14):1320-9.

Megens MR, Churilov L, Thijs V. New-onset atrial fibrillation after coronary artery bypass graft and long-term risk of stroke: a meta-analysis. J Am Heart Assoc. 2017;6(12):e007558.

Bidar E, Zeemering S, Gilbers M, Isaacs A, Verheule S, Zink MD, et al. Clinical and electrophysiological predictors of device-detected new-onset atrial fibrillation during 3 years after cardiac surgery. Europace. 2021;23(12):1922-30.

Wickbom A, Fengsrud E, Alfredsson J, Engdahl J, Kalm T, Ahlsson A. Atrial fibrillation incidence after coronary artery bypass graft surgery and percutaneous coronary intervention: the prospective AFAF cohort study. Scand Cardiovasc J. 2024;58(1):2347297.

Connolly MW. Current results of off-pump coronary artery bypass surgery. Semin Thorac Cardiovasc Surg. 2003;15(1):45-51.

Livesay JJ. The benefits of off-pump coronary bypass: a reality or an illusion? Tex Heart Inst J. 2003;30(4):258-60.

Patel A, Dunning J. Is sotalol more effective than standard beta-blockers for the prophylaxis of atrial fibrillation during cardiac surgery? Interact Cardiovasc Thorac Surg. 2005;4(2):147-50.

Auer J, Weber T, Berent R, Ng CK, Lamm G, Eber B. Postoperative atrial fibrillation independently predicts prolongation of hospital stay after cardiac surgery. J Cardiovasc Surg (Torino). 2005;46(6):583-8.

Janssen J, Loomans L, Harink J, Taams M, Brunninkhuis L, van der Starre P, et al. Prevention and treatment of supraventricular tachycardia shortly after coronary artery bypass grafting: a randomized open trial. Angiology. 1986;37(8):601-9.

Parikka H, Toivonen L, Heikkilä L, Virtanen K, Järvinen A. Comparison of sotalol and metoprolol in the prevention of atrial fibrillation after coronary artery bypass surgery. J Cardiovasc Pharmacol. 1998;31(1):67-73.

Aerra V, Kuduvalli M, Moloto AN, Srinivasan AK, Grayson AD, Fabri BM, et al. Does prophylactic sotalol and magnesium decrease the incidence of atrial fibrillation following coronary artery bypass surgery: a propensity-matched analysis. J Cardiothorac Surg. 2006;1:6.

Ghurram A, Krishna N, Bhaskaran R, Kumaraswamy N, Jayant A, Varma PK. Patients who develop post-operative atrial fibrillation have reduced survival after off-pump coronary artery bypass grafting. Indian J Thorac Cardiovasc Surg. 2020;36(1):6-13.

Sanjuán R, Blasco M, Carbonell N, Jordá A, Núñez J, Martínez-León J, et al. Preoperative use of sotalol versus atenolol for atrial fibrillation after cardiac surgery. Ann Thorac Surg. 2004;77(3):838-43.

Gomes JA, Ip J, Santoni-Rugiu F, Mehta D, Ergin A, Lansman S, et al. Oral d,l-sotalol reduces the incidence of postoperative atrial fibrillation in coronary artery bypass surgery patients: a randomized, double-blind, placebo-controlled study. J Am Coll Cardiol. 1999;34(2):334-9.

Johnson SMA, Brophy JM. Mortality risk of sotalol and amiodarone for post-CABG atrial fibrillation. Int J Cardiol. 2016;214:502-7.

Mooss AN, Wurdeman RL, Sugimoto JT, Packard KA, Hilleman DE, Lenz TL, et al. Amiodarone versus sotalol for the treatment of atrial fibrillation after open heart surgery: the Reduction in Postoperative Cardiovascular Arrhythmic Events (REDUCE) trial. Am Heart J. 2004;148(4):641-8.

Amr YM, Elmistekawy EM, Hammad AA. Intraoperative loading dose of amiodarone for prophylaxis against atrial fibrillation after valvular heart surgery. Anesth Essays Res. 2010;4(2):96-101.